Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Shares outstanding
- 62,650,155
- Total 13F shares
- 49,737,058
- Share change
- +671,601
- Total reported value
- $4,761,682,266
- Put/Call ratio
- 73%
- Price per share
- $95.79
- Number of holders
- 241
- Value change
- +$3,495,565
- Number of buys
- 113
- Number of sells
- 146
Quarterly Holders Quick Answers
What is CUSIP 78667J108?
CUSIP 78667J108 identifies SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 78667J108:
Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
12%
|
7,752,634
|
$1,095,060,000 | — | 30 Sep 2018 | |
| FMR LLC |
13F
|
Company |
11%
|
6,999,644
|
$988,700,000 | — | 30 Sep 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.5%
|
4,085,812
|
$577,121,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
2,816,410
|
$397,818,000 | — | 30 Sep 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.1%
|
1,970,770
|
$278,372,000 | — | 30 Sep 2018 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
2.5%
|
1,583,620
|
$223,687,000 | — | 30 Sep 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.5%
|
1,548,360
|
$218,707,000 | — | 30 Sep 2018 | |
| BB BIOTECH AG |
13F
|
Company |
1.7%
|
1,071,373
|
$151,331,000 | — | 30 Sep 2018 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,005,545
|
$142,035,000 | — | 30 Sep 2018 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.5%
|
950,773
|
$134,277,000 | — | 30 Sep 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
936,058
|
$132,217,000 | — | 30 Sep 2018 | |
| Palo Alto Investors LP |
13F
|
Company |
1.3%
|
840,372
|
$118,703,000 | — | 30 Sep 2018 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.3%
|
810,224
|
$114,444,000 | — | 30 Sep 2018 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
1%
|
654,014
|
$92,379,000 | — | 30 Sep 2018 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
625,000
|
$88,281,000 | — | 30 Sep 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.92%
|
577,494
|
$81,571,000 | — | 30 Sep 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.91%
|
567,497
|
$80,159,000 | — | 30 Sep 2018 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.78%
|
489,801
|
$69,781,000 | — | 30 Sep 2018 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
494,000
|
$69,778,000 | — | 30 Sep 2018 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.78%
|
489,148
|
$69,092,000 | — | 30 Sep 2018 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.71%
|
447,906
|
$63,267,000 | — | 30 Sep 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
435,884
|
$61,568,000 | — | 30 Sep 2018 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.67%
|
420,735
|
$59,429,000 | — | 30 Sep 2018 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.66%
|
414,296
|
$58,519,000 | — | 30 Sep 2018 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.62%
|
391,548
|
$55,306,000 | — | 30 Sep 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.62%
|
388,706
|
$54,905,000 | — | 30 Sep 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
358,699
|
$50,666,000 | — | 30 Sep 2018 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.56%
|
350,933
|
$49,569,000 | — | 30 Sep 2018 | |
| NORGES BANK |
13F
|
Company |
0.54%
|
336,344
|
$47,509,000 | — | 30 Sep 2018 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.53%
|
329,837
|
$46,292,000 | — | 30 Sep 2018 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.51%
|
321,596
|
$45,425,000 | — | 30 Sep 2018 | |
| Casdin Capital, LLC |
13F
|
Company |
0.5%
|
312,000
|
$44,070,000 | — | 30 Sep 2018 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.48%
|
300,565
|
$42,455,000 | — | 30 Sep 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.43%
|
266,868
|
$37,695,000 | — | 30 Sep 2018 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.42%
|
264,663
|
$37,384,000 | — | 30 Sep 2018 | |
| Fiera Capital Corp |
13F
|
Company |
0.42%
|
263,535
|
$37,224,000 | — | 30 Sep 2018 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.38%
|
241,099
|
$34,055,000 | — | 30 Sep 2018 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.38%
|
236,919
|
$33,465,000 | — | 30 Sep 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
224,143
|
$31,660,000 | — | 30 Sep 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.35%
|
221,359
|
$31,267,000 | — | 30 Sep 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
220,349
|
$31,125,000 | — | 30 Sep 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
208,385
|
$29,435,000 | — | 30 Sep 2018 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.31%
|
193,730
|
$27,286,000 | — | 30 Sep 2018 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.3%
|
190,000
|
$26,838,000 | — | 30 Sep 2018 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.29%
|
181,126
|
$25,584,047 | — | 30 Sep 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.29%
|
179,022
|
$25,287,000 | — | 30 Sep 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
177,551
|
$25,080,000 | — | 30 Sep 2018 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.28%
|
175,000
|
$24,719,000 | — | 30 Sep 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.28%
|
172,676
|
$24,391,000 | — | 30 Sep 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.27%
|
169,705
|
$23,971,000 | — | 30 Sep 2018 |
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2018
As of 31 Dec 2018,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
241 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,737,058 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Vanguard Group Inc, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, OppenheimerFunds, Inc., BB BIOTECH AG, STATE STREET CORP, and FRANKLIN RESOURCES INC.
This page lists
241
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
272
Q4 2018 holders
241
Holder diff
-31
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.